ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IOVA Iovance Biotherapeutics Inc

14.90
0.80 (5.67%)
After Hours
Last Updated: 17:03:51
Delayed by 15 minutes

Period:

Draw Mode:

Volume 6,186,586
Bid Price 14.73
Ask Price 14.90
News -
Day High 15.18

Low
3.21

52 Week Range

High
18.33

Day Low 14.10
Company Name Stock Ticker Symbol Market Type
Iovance Biotherapeutics Inc IOVA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.80 5.67% 14.90 17:03:51
Open Price Low Price High Price Close Price Prev Close
14.12 14.10 15.18 14.82 14.10
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
36,034 6,186,586 $ 14.77 $ 91,360,879 - 3.21 - 18.33
Last Trade Time Type Quantity Stock Price Currency
17:12:31 3 $ 14.90 USD

Iovance Biotherapeutics (IOVA) Options Flow Summary

Overall Flow

Bullish

Net Premium

320k

Calls / Puts

100.00%

Buys / Sells

20.00%

OTM / ITM

50.00%

Sweeps Ratio

0.17%

Iovance Biotherapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.13B 279.31M - 1.19M -444.04M -1.59 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Iovance Biotherapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No IOVA Message Board. Create One! See More Posts on IOVA Message Board See More Message Board Posts

Historical IOVA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week15.0415.9013.7514.684,952,644-0.14-0.93%
1 Month16.8318.2413.6015.368,232,008-1.93-11.47%
3 Months7.9318.337.3412.879,947,9336.9787.89%
6 Months4.4818.333.219.608,478,88610.42232.59%
1 Year6.1118.333.218.517,102,8668.79143.86%
3 Years28.2833.993.2110.894,406,227-13.38-47.31%
5 Years9.4154.20813.2114.333,255,9075.4958.34%

Iovance Biotherapeutics Description

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. Its lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes to treat patients with refractory metastatic melanoma.

Your Recent History

Delayed Upgrade Clock